The profitability of EXELON CORPORATION over the past 10 years
Chart EXELON CORPORATION: operating income, net income, fiscal 2016–2025 Open the chart →EXELON CORPORATION reported net income of $2.77B in fiscal 2025, the latest fiscal year on file. That year it had operating income of $5.15B. It reported a profit in all 10 years shown. Its highest net income in these years was $3.87B, in fiscal 2017.
Year by year
| Fiscal year | Operating income | Net income |
|---|---|---|
| 2025ended Dec 31, 2025 | $5.15B | $2.77B |
| 2024ended Dec 31, 2024 | $4.32B | $2.46B |
| 2023ended Dec 31, 2023 | $4.02B | $2.33B |
| 2022ended Dec 31, 2022 | $3.31B | $2.17B* |
| 2021ended Dec 31, 2021 | $2.68B | $1.71B* |
| 2020ended Dec 31, 2020 | $2.19B | $1.96B* |
| 2019ended Dec 31, 2019 | $2.66B | $2.94B* |
| 2018ended Dec 31, 2018 | $3.89B | $2B* |
| 2017ended Dec 31, 2017 | $4.39B | $3.87B |
| 2016ended Dec 31, 2016 | $3.21B | $1.2B |
Fiscal years as EXELON CORPORATION reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on EXELON CORPORATION
- The revenue of EXELON CORPORATION
- The cash flow of EXELON CORPORATION
- The debt of EXELON CORPORATION
- The dividends of EXELON CORPORATION
- All of EXELON CORPORATION's financials, charted
Companies of a similar size
- MNSTMonster Beverage Corp
- MSCIMSCI INC.
- AMPAMERIPRISE FINANCIAL, INC.
- IDXXIDEXX LABORATORIES INC /DE
- TEVATEVA PHARMACEUTICAL INDUSTRIES LIMITED
Not investment advice. This page shows what EXELON CORPORATION filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.